Emitents | Olainfarm, AS (213800WCG52W62ENOP27) |
Veids | Citi |
Valoda | EN |
Statuss | Publicēts |
Versija | |
Datums | 2014-09-11 10:00:13 |
Versijas komentārs | |
Teksts |
Second Quarter 2014 Investor Conference Webinar
On September 10 AS „Olainfarm” organized its second quarter 2014
Investor Conference Online Webinar. During the webinar the member
of the management board of AS „Olainfarm” Salvis Lapiņš analysed
the financial results of second quarter 2014 and informed about the
company’s future activities, paying extra attention to Russian
market.
The recorded “Olainfarm” webinar is available online:
http://ej.uz/OLF_Q2_2014,
and the presentation, demonstrated during the webinar, can be found
in the previously published AS “Olainfarm” announcement:
https://newsclient.omxgroup.com/cdsPublic/viewDisclosure.action?disclosureId=623968&messageId=774129.
Olainfarm thanks all participants, who joined the webinar, and
encourages everybody to follow company’s announcements to get
information on the next webinar!
JSC Olainfarm is one of the biggest pharmaceutical companies
in Latvia with more than 40 years of experience in production of
medication and chemical and pharmaceutical products. A basic
principle of company's operations is to produce reliable and
effective top quality products for Latvia and the rest of the
world. Products made by the Group are being exported to more than
35 countries of the world, including the Baltics, Russia, other
CIS, Europe, Asia, North America and Australia.
Information prepared
by:
Salvis
Lapins |
Pielikumi |
|